Computer-Aided Design of Orally Bioavailable Pyrrolidine Carboxamide Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis with Favorable Pharmacokinetic Profiles-Reference-Cited by-同舟云学术

Computer-Aided Design of Orally Bioavailable Pyrrolidine Carboxamide Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis with Favorable Pharmacokinetic Profiles

Published:2015-12-12 Issue:12 Volume:16 Page:29744-29771
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Kouassi Affiba,Kone Mawa,Keita Melalie,Esmel Akori,Megnassan Eugene,N’Guessan Yao,Frecer Vladimir,Miertus Stanislav

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/16/12/26196/pdf

Reference44 articles.

1. Global Tuberculosis Report 2014,2014

2. Inactivation of the inhA -Encoded Fatty Acid Synthase II (FASII) Enoyl-Acyl Carrier Protein Reductase Induces Accumulation of the FASI End Products and Cell Lysis of Mycobacterium smegmatis

3. Genomic-scale prioritization of drug targets: the TDR Targets database

4. Bacterial Fatty Acid Biosynthesis: Targets for Antibacterial Drug Discovery

5. Mechanisms of action of isoniazid

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards the development of better therapeutic agents for Mycobacterium Tuberculosis: Computational design and evaluation of pyrazinone derivatives as inhibitors of enoyl acyl carrier protein reductase;2024-07-18

2. Towards the Development of Better Therapeutic Agents for Mycobacterium Tuberculosis: Computational Design and Evaluation of Pyrazinone Derivatives as Inhibitors of Enoyl Acyl Carrier Protein Reductase;2024

3. Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of Plasmodium falciparum with Favourable ADME Profiles;International Journal of Molecular Sciences;2023-04-07

4. Anti-tuberculosis drug development via targeting the cell envelope of Mycobacterium tuberculosis;Frontiers in Microbiology;2022-12-21

5. Computer-Aided Design of Peptidomimetic Inhibitors of Falcipain-3: QSAR and Pharmacophore Models;Scientia Pharmaceutica;2021-09-29